The latest trend in health and fitness tracking may sound familiar: wearing continuous glucose monitors (CGMs). Many people ...

The stock's fall snapped a two-day winning streak.

Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling is when a trader sells shares of a company they do not own, with the hope ...

Wells Fargo analyst Larry Biegelsen maintained a Buy rating on Dexcom (DXCM – Research Report) yesterday and set a price target of $98.00. The ...

Both stocks should deliver excellent returns to investors patient enough to hold through volatility. Equity markets started ...

Insulet (Nasdaq:PODD) announced today that it made its Omnipod 5 automated insulin delivery system available in several new ...

DexCom DXCM received a warning letter from the FDA on March 4, 2025, following inspections of its San Diego and Mesa facilities in 2024. The FDA cited deficiencies in the company’s manufacturing ...

Analysts at William Blair reduced their Q1 2025 earnings estimates for shares of DexCom in a research note issued to ...

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range ...

President Trump signed an executive order Tuesday that reaffirmed a priority from his first term: making health care prices public and easier for people to understand. The executive order promises ...

(NASDAQ:DXCM), the global leader in glucose biosensing, has announced the appointment of Renée Galá to its board of directors ...

The recent selloff of U.S. equities continued at midday on fears the U.S. economy could be heading toward a recession. The Nasdaq sank 3%, the S&P 500 dipped about 2%, and the Dow Jones Industrial ...